BAD NEWS: The reliability of clinical tests used to win approval for some medicines — particularly generic copies of original drugs — could be in doubt due to an apparent software glitch that may mean data was calculated incorrectly. — Reuters
LONDON: The reliability of clinical tests used to win approval for some medicines — particularly generic copies of original drugs — could be in doubt due to an apparent software glitch that may mean data was calculated incorrectly.
An official at the London-based European Medicines Agency (EMA) told Reuters that the issue, involving Thermo Fisher Scientific's Kinetica package, would be discussed by European regulators at a meeting next week.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
